New Perspectives and Open Issues in the Adjuvant and Neoadjuvant Treatment of Melanoma

Abstract excerpt

Melanoma adjuvant therapy has substantially improved recurrence-free and distant metastasis-free survival in patients with resected high-risk disease, and more recently these advances have extended to earlier stages. However, important unmet needs remain, including the management of stage IIIA disease, the optimal treatment strategy after relapse on adjuvant therapy, and the identification of biomarkers capable of...

Topics

Open a Topic to create a Post that cites this publication.

• Biomarkers, Tumor
• Cancer Immunotherapy and Biomarkers
• CAR-T cell therapy research
• Circulating Tumor DNA
• Immunotherapy and Immune Responses
• Melanoma
• Mutation
• Skin Neoplasms

Identifiers and source

Literature Corpus work

0de44743-1360-5991-ba69-a11b78bb44d0

DOI

10.20944/preprints202604.1541.v1